Divalprid-OD 250 Tablet PR
Marketer
Micro Labs Ltd
Salt Composition
Divalproex (250mg)
Overview Divalprid-OD 250 Tablet PR
Sodium valproate 250mg extended-release tablets are prescribed for epilepsy management, effectively preventing and controlling seizures. This medication also finds application in migraine prophylaxis and, in some cases, bipolar disorder treatment. Dosage and frequency are determined individually by your physician to optimize symptom control, and may be used alone or in conjunction with other medications. Administer with or without food, consistently at the same time daily for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Continuous use, as directed, is crucial; missed doses or abrupt cessation can provoke seizures or worsen your condition. Discontinuation should always be gradual and under medical supervision. Common side effects, often mild, include headache, visual blurring, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. Persistent or bothersome side effects warrant medical consultation. Report any skin rash or redness immediately. Long-term use can potentially reduce bone density (osteoporosis), increasing fracture risk. Rarely, suicidal ideation or behavior may occur; inform your doctor of any mood changes. Prior to commencing treatment, disclose any history of heart, kidney, or liver disease, urinary difficulties, depression, or suicidal thoughts. Numerous drug interactions are possible; provide your doctor with a complete medication list to ensure safety and compatibility. Pregnant individuals should consult their physician before initiating or discontinuing this medication. Alcohol consumption should be avoided due to potential exacerbation of side effects and increased seizure risk. Regular blood tests, both pre- and post-treatment initiation, are often necessary for optimal dosage adjustment.
Uses of Divalprid-OD 250 Tablet PR
Managing epileptic seizures and bipolar disorder; migraine prophylaxis.
Major Benefits of Divalprid-OD 250 Tablet PR:
Follow your physician's instructions or consult the product label for usage guidelines. The Divalprid-OD 250mg tablet may be administered with or without food; however, consistent daily timing is recommended.
Common Side effects of Divalprid-OD 250 Tablet PR:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Divalprid-OD 250 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for proper administration. Divalprid-OD 250mg tablets can be ingested with or without food, however, consistent daily timing is recommended.
How Divalprid-OD 250 Tablet PR works:
Depakote 250mg extended-release tablets are used to manage epilepsy. This medication works by reducing heightened, irregular neuronal firing in the brain, thus controlling seizures.
SAFETY ADVICE
AlcoholUNSAFE
Taking Divalproex sodium extended-release 250 mg tablets with alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Divalproex sodium 250 mg extended-release tablets during pregnancy carries a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Depakote ER 250 mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Taking Divalproex sodium 250 mg extended-release tablets may induce adverse reactions that impair driving capabilities.
KidneySAFE IF PRESCRIBED
Valproic acid extended-release 250 mg tablets are considered safe for use in individuals with renal impairment. No alteration in dosage of valproic acid extended-release 250 mg tablets is necessary.
LiverUNSAFE
Use of Divalprid-OD 250 mg extended-release tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.
What if you forget to take Divalprid-OD 250 Tablet PR :
Should you forget to take your Divalprid-OD 250 Tablet PR, ingest the dose at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Divalprid-OD 250 Tablet PR
| Label | Value |
|---|---|
| Chemical Category | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Action Class | Anticonvulsant sodium channel blockers |






